These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 24533541)
21. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents. Eroglu FK; Beşbaş N; Topaloglu R; Ozen S Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859 [TBL] [Abstract][Full Text] [Related]
22. A Case of Protracted Febrile Myalgia Syndrome with Atypical Course and Severe Asymmetric Loss of Muscle Strength. Deniz R; Mandacı A; Gerdan I; Özgür DS; Karaalioğlu B; Akkuzu G; Yıldırım F; Bes C Mediterr J Rheumatol; 2023 Dec; 34(4):550-554. PubMed ID: 38282944 [TBL] [Abstract][Full Text] [Related]
23. The clinical role of anakinra in the armamentarium against familial Mediterranean fever. Parlar K; Ates MB; Egeli BH; Ugurlu S Expert Rev Clin Immunol; 2024 May; 20(5):441-453. PubMed ID: 38133629 [TBL] [Abstract][Full Text] [Related]
24. Protracted febrile myalgia syndrome treated with pulse of corticosteroids. Rom E; Amarilyo G; Levinski Y; Bilavsky E; Goldberg O; Amir J; Harel L Semin Arthritis Rheum; 2018 Jun; 47(6):897-899. PubMed ID: 29129325 [TBL] [Abstract][Full Text] [Related]
25. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment. Karabulut Y; Gezer HH; Duruöz MT Rheumatol Int; 2022 Jan; 42(1):81-86. PubMed ID: 34550430 [TBL] [Abstract][Full Text] [Related]
26. Protracted febrile myalgia syndrome in a kidney transplant recipient with familial Mediterranean fever. Abdel Halim MM; Al-Otaibi T; Donia F; Gheith O; Asif P; Nawas M; Rashad RH; Said T; Nair P; Nampoory N Exp Clin Transplant; 2015 Apr; 13(2):188-92. PubMed ID: 24650330 [TBL] [Abstract][Full Text] [Related]
27. Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure. Stankovic Stojanovic K; Delmas Y; Torres PU; Peltier J; Pelle G; Jéru I; Colombat M; Grateau G Nephrol Dial Transplant; 2012 May; 27(5):1898-901. PubMed ID: 21931121 [TBL] [Abstract][Full Text] [Related]
28. Clinical quiz: a pediatric case presenting with fever and diffuse myalgia. Soylu A; Oztürk Y; Kasap B; Akman N; Türkmen M; Kavukçu S Rheumatol Int; 2005 May; 25(4):314-6. PubMed ID: 15889305 [TBL] [Abstract][Full Text] [Related]
29. Myositis in a patient with familial Mediterranean fever and spondyloarthritis successfully treated with anakinra. Estublier C; Stankovic Stojanovic K; Bergerot JF; Broussolle C; Sève P Joint Bone Spine; 2013 Dec; 80(6):645-9. PubMed ID: 23928237 [TBL] [Abstract][Full Text] [Related]
30. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine. Ozen S; Bilginer Y; Aktay Ayaz N; Calguneri M J Rheumatol; 2011 Mar; 38(3):516-8. PubMed ID: 21159830 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study. Babaoglu H; Varan O; Kucuk H; Atas N; Satis H; Salman R; Ozturk MA; Goker B; Tufan A; Haznedaroglu S J Clin Rheumatol; 2020 Jan; 26(1):7-13. PubMed ID: 30048391 [TBL] [Abstract][Full Text] [Related]
33. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report. Peces R; Afonso S; Peces C; Nevado J; Selgas R BMC Med Genet; 2017 Aug; 18(1):97. PubMed ID: 28859624 [TBL] [Abstract][Full Text] [Related]
34. IL-1 inhibition in familial Mediterranean fever: clinical outcomes and expectations. Kharouf F; Tsemach-Toren T; Ben-Chetrit E Clin Exp Rheumatol; 2022 Sep; 40(8):1567-1574. PubMed ID: 36062765 [TBL] [Abstract][Full Text] [Related]
35. IL-1 blockers together with colchicine may be administered as first line therapy in familial Mediterranean fever with amyloidosis. Tezcan ME Med Hypotheses; 2019 Sep; 130():109269. PubMed ID: 31383341 [TBL] [Abstract][Full Text] [Related]
36. Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine. Roldan R; Ruiz AM; Miranda MD; Collantes E Joint Bone Spine; 2008 Jul; 75(4):504-5. PubMed ID: 18541452 [TBL] [Abstract][Full Text] [Related]
37. Febrile myalgia syndrome in familial Mediterranean fever. Soylu A; Kasap B; Türkmen M; Saylam GS; Kavukçu S J Clin Rheumatol; 2006 Apr; 12(2):93-6. PubMed ID: 16601545 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Meinzer U; Quartier P; Alexandra JF; Hentgen V; Retornaz F; Koné-Paut I Semin Arthritis Rheum; 2011 Oct; 41(2):265-71. PubMed ID: 21277619 [TBL] [Abstract][Full Text] [Related]
39. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder. Portincasa P; Scaccianoce G; Palasciano G Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178 [TBL] [Abstract][Full Text] [Related]
40. Further Observations on the Occurrence of Protracted Febrile Myalgia of Familial Mediterranean Fever. Ling E; Ling G; Golan YBB J Clin Rheumatol; 2021 Dec; 27(8S):S348-S350. PubMed ID: 33065631 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]